Very Tough Day Wall Street
|The stock market indices had a topsy-turvy day with a pop at the opening, a sharp selloff that held support, then a huge rally that took the Nasdaq 100 from 4849 to 4897, and the S&P 500 from 2198 to 2209. In the afternoon, they consolidated and it looked like they were going higher, but when they failed to do so, they pulled back very sharply, and took a fifty percent retrace of the whole rally, and then had a little bounce at the close. They managed to close positive. But it wasn’t a very spectacular day.
Net on the day, the Dow was up 23.70 at 19,121.60. The S&P 500 was up 2.94 at 2204.66. The Nasdaq 100 was up 16.19 at 4873.21.
Advance-declines were positive by 80 issues on the Nasdaq. The Nasdaq traded 1.7 billion shares and had an 8 to 7 positive volume ratio.
TheTechTrader.com board was very mixed today. Priceline.com (PCLN) was down 4.80 to 1520.27, Apple Inc. (AAPL) down 12 cents to 111.44, Amazon.com, Inc. (AMZN) down 5.22 to 761.55, but Alphabet Inc. (GOOG) gained 2.60 to 770.84 as did Netflix, Inc. (NFLX), up 58 cents to 117.51.
Baidu, Inc. (BIDU) popped 2.18 to 169.18, Facebook, Inc. (FB) gained 46 cents to 120.87, but First Solar, Inc. (FSLR) dropped 1.16 to 29.95.
Tesla Motors, Inc. (TSLA) Tesla Motors, Inc. (TSLA) lost 6.55 to 189.67.
Acacia Communications, Inc. (ACIA) was also down 2.26 to 70.67.
To the upside, gainers included CoLucid Pharmaceuticals, Inc. (CLCD), up 2.35 to 36.25, Sucampo Pharmaceuticals, Inc. (SCMP) up 1.00 to 17.15, and Clovis Oncology Inc (CLVS) 1.21 to 35.60.
The Direxion Daily S&P Biotech Bull 3X ETF (LABU) got hit back and closed-up just 38 cents to 41.52.
It was a very tough picture on Wall Street today, and tough to tell what that means directionally. Although we did have a new high for this entire rally on the Nasdaq 100, they failed to confirm on the S&P 500.
It could be a negative divergence, but we’ll just have to wait to see how it goes tomorrow.
Good Trading!
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.